Really like the last two paragraphs.
Jimbo
CSI Expands Staff to Exploit Antisense Technology
July 9, 1998 07:18 PM
HOUSTON--(BUSINESS WIRE)--July 9, 1998--Cryogenic Solutions Inc CYGS named
Laurence Mealey as Vice President for Commercial Development. "Mr. Mealey
brings the kind of high level multinational corporate experience that we need to
optimize the value of biotechnology as far reaching as the ssDNA expression vector
promises to be." said Board Chairman, Dell Gibson.
Laurence Mealey was born in England where he earned his BME and MBA degrees.
He has over three decades experience as CEO, CFO or COO with such
international companies as Gulf and Western, The Laird Group in London, and Inco
of Canada. Using "hands on " experience, Mr. Mealey has enabled fledgling
companies to realize their full market potential as well as improving efficiency and
profitability of existing companies. His international successes have included
activities in nearly every European country as well as Brazil, Mexico, Canada, and of
course the US.
In April 1997, CSI licensed technology and began perfecting the patent for their
TeloVector(TM) designed to synthesize sequence specific single strands of DNA
(ssDNA) in cells (in vivo) to repair telomere ends shortened during cell division
(mitosis). The same basic technology promises to be the missing piece to the
antisense efficacy puzzle, namely a dependable method of delivering the antisense
molecules into the cells of living organisms where they can do their job of disabling
or modifying the behavior of the rogue genes that cause many of our more common
and devastating diseases including HIV, Herpes, Hepatitis C, and most kinds of
Cancer.
According to a March 96 analysis by "Scrip Reports", "By the year 2000 the total
value of the market for antisense therapies is expected to be $1.1 billion. And this
figure is expected to nearly double to $2.12 billion by the year 2005. " It was
estimated that the figure will be many times higher when a dependable delivery
mechanism is available.
"Although the term 'antisense' is not a household word, it is well recognized in the
realm of biotech companies exploring leading edge genetic therapies," said Mr.
Mealey. "In my view, Antisense therapeutics is the singular most significant medical
break through since the discovery of effective vaccines."
Top
------
Previous
Edit your message
|
